Cancer Genetics and Genomics Clinical Sequencing Consortium

Clinical Sequencing Evidence-Generating Research (CSER – Phase 2): The Texas KidsCanSeq Study

The Baylor College of Medicine Texas KidsCanSeq Study is one of six studies funded by the National Institutes of Health to further our understanding of the best way to incorporate different types of new genomic tests into the care of childhood cancer patients including those newly diagnosed with cancer and those children where the tumor may have returned. The Texas KidsCanSeq project aims to assess the usefulness of different types of genomic tests in diverse pediatric cancer patient populations and diverse healthcare settings in many different cities in Texas. 

Clinical Sequencing Evidence-Generating Research (CSER): BASIC3

BASIC3 was one of the initial NIH’s Clinical Sequencing Exploratory Research (CSER) program studies. The project’s goal was to develop the first clinical genomic tests that were used for children diagnosed with cancer, which were developed by working with the Human Genome Sequencing Center. We evaluated the best way to integrate genomic sequence data into the care of childhood cancer patients who had been newly diagnosed with solid tumors and brain tumors.